nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—peripheral nervous system neoplasm—malignant glioma	0.548	1	CtDrD
Tretinoin—CYP2C18—malignant glioma	0.17	0.574	CbGaD
Tretinoin—CYP2B6—malignant glioma	0.126	0.426	CbGaD
Tretinoin—Behavior disorder—Temozolomide—malignant glioma	0.00291	0.0494	CcSEcCtD
Tretinoin—CRABP2—pineal body—malignant glioma	0.00289	0.0925	CbGeAlD
Tretinoin—Teratogenicity—Carmustine—malignant glioma	0.00166	0.0281	CcSEcCtD
Tretinoin—Brain oedema—Carmustine—malignant glioma	0.00122	0.0206	CcSEcCtD
Tretinoin—Brain oedema—Temozolomide—malignant glioma	0.00117	0.0199	CcSEcCtD
Tretinoin—ALDH1A2—embryo—malignant glioma	0.00113	0.0361	CbGeAlD
Tretinoin—Facial paralysis—Carmustine—malignant glioma	0.00109	0.0185	CcSEcCtD
Tretinoin—CRABP1—embryo—malignant glioma	0.00109	0.0348	CbGeAlD
Tretinoin—Sensory disturbance—Temozolomide—malignant glioma	0.00108	0.0184	CcSEcCtD
Tretinoin—Retinal haemorrhage—Carmustine—malignant glioma	0.00107	0.0181	CcSEcCtD
Tretinoin—CRABP1—brainstem—malignant glioma	0.000996	0.0319	CbGeAlD
Tretinoin—CRABP2—embryo—malignant glioma	0.000983	0.0315	CbGeAlD
Tretinoin—Hemiplegia—Carmustine—malignant glioma	0.000972	0.0165	CcSEcCtD
Tretinoin—CRABP1—retina—malignant glioma	0.000961	0.0308	CbGeAlD
Tretinoin—Hemiplegia—Temozolomide—malignant glioma	0.00094	0.0159	CcSEcCtD
Tretinoin—Clotting—Temozolomide—malignant glioma	0.00094	0.0159	CcSEcCtD
Tretinoin—Abnormal behaviour—Temozolomide—malignant glioma	0.000901	0.0153	CcSEcCtD
Tretinoin—VIIth nerve paralysis—Carmustine—malignant glioma	0.000847	0.0144	CcSEcCtD
Tretinoin—Intracranial pressure increased—Carmustine—malignant glioma	0.000831	0.0141	CcSEcCtD
Tretinoin—ALDH1A1—embryo—malignant glioma	0.000819	0.0262	CbGeAlD
Tretinoin—Impaired healing—Carmustine—malignant glioma	0.000803	0.0136	CcSEcCtD
Tretinoin—RXRA—telencephalon—malignant glioma	0.000796	0.0255	CbGeAlD
Tretinoin—ALDH1A1—brainstem—malignant glioma	0.00075	0.024	CbGeAlD
Tretinoin—Lung infiltration—Carmustine—malignant glioma	0.000741	0.0126	CcSEcCtD
Tretinoin—Disorder sight—Temozolomide—malignant glioma	0.000705	0.012	CcSEcCtD
Tretinoin—CRABP1—medulla oblongata—malignant glioma	0.000694	0.0222	CbGeAlD
Tretinoin—ALDH1A1—telencephalon—malignant glioma	0.000666	0.0213	CbGeAlD
Tretinoin—RXRB—telencephalon—malignant glioma	0.000657	0.021	CbGeAlD
Tretinoin—CRABP1—midbrain—malignant glioma	0.000635	0.0203	CbGeAlD
Tretinoin—RARG—retina—malignant glioma	0.000634	0.0203	CbGeAlD
Tretinoin—CRABP2—medulla oblongata—malignant glioma	0.000628	0.0201	CbGeAlD
Tretinoin—Cerebral haemorrhage—Carmustine—malignant glioma	0.000627	0.0106	CcSEcCtD
Tretinoin—CRABP1—spinal cord—malignant glioma	0.000619	0.0198	CbGeAlD
Tretinoin—Cerebral haemorrhage—Temozolomide—malignant glioma	0.000606	0.0103	CcSEcCtD
Tretinoin—Skin hyperpigmentation—Carmustine—malignant glioma	0.000584	0.0099	CcSEcCtD
Tretinoin—Febrile neutropenia—Carmustine—malignant glioma	0.000577	0.00979	CcSEcCtD
Tretinoin—Visual acuity reduced—Temozolomide—malignant glioma	0.000564	0.00957	CcSEcCtD
Tretinoin—CRABP2—spinal cord—malignant glioma	0.00056	0.0179	CbGeAlD
Tretinoin—Febrile neutropenia—Temozolomide—malignant glioma	0.000558	0.00946	CcSEcCtD
Tretinoin—RXRG—medulla oblongata—malignant glioma	0.000549	0.0176	CbGeAlD
Tretinoin—RARA—telencephalon—malignant glioma	0.000548	0.0176	CbGeAlD
Tretinoin—Encephalopathy—Carmustine—malignant glioma	0.000541	0.00917	CcSEcCtD
Tretinoin—RARRES1—brain—malignant glioma	0.000539	0.0172	CbGeAlD
Tretinoin—Aphasia—Carmustine—malignant glioma	0.000535	0.00908	CcSEcCtD
Tretinoin—ALDH1A1—medulla oblongata—malignant glioma	0.000523	0.0168	CbGeAlD
Tretinoin—Embolism—Temozolomide—malignant glioma	0.000523	0.00886	CcSEcCtD
Tretinoin—ALDH1A2—central nervous system—malignant glioma	0.000521	0.0167	CbGeAlD
Tretinoin—Aphasia—Temozolomide—malignant glioma	0.000517	0.00877	CcSEcCtD
Tretinoin—ALDH1A2—cerebellum—malignant glioma	0.000509	0.0163	CbGeAlD
Tretinoin—CRABP1—central nervous system—malignant glioma	0.000502	0.0161	CbGeAlD
Tretinoin—RXRG—midbrain—malignant glioma	0.000502	0.0161	CbGeAlD
Tretinoin—CRABP1—cerebellum—malignant glioma	0.000491	0.0157	CbGeAlD
Tretinoin—Thrombosis—Carmustine—malignant glioma	0.000491	0.00832	CcSEcCtD
Tretinoin—RXRG—spinal cord—malignant glioma	0.000489	0.0157	CbGeAlD
Tretinoin—ALDH1A1—midbrain—malignant glioma	0.000478	0.0153	CbGeAlD
Tretinoin—Lung disorder—Temozolomide—malignant glioma	0.000474	0.00804	CcSEcCtD
Tretinoin—ALDH1A1—spinal cord—malignant glioma	0.000467	0.0149	CbGeAlD
Tretinoin—NR0B1—brain—malignant glioma	0.000464	0.0148	CbGeAlD
Tretinoin—Scotoma—Carmustine—malignant glioma	0.000457	0.00775	CcSEcCtD
Tretinoin—CRABP2—central nervous system—malignant glioma	0.000454	0.0145	CbGeAlD
Tretinoin—RXRA—central nervous system—malignant glioma	0.000452	0.0145	CbGeAlD
Tretinoin—Hepatotoxicity—Carmustine—malignant glioma	0.00045	0.00762	CcSEcCtD
Tretinoin—CRABP2—cerebellum—malignant glioma	0.000444	0.0142	CbGeAlD
Tretinoin—Scotoma—Temozolomide—malignant glioma	0.000442	0.00749	CcSEcCtD
Tretinoin—Hepatotoxicity—Temozolomide—malignant glioma	0.000435	0.00737	CcSEcCtD
Tretinoin—Coagulopathy—Temozolomide—malignant glioma	0.000431	0.00731	CcSEcCtD
Tretinoin—Memory impairment—Temozolomide—malignant glioma	0.000428	0.00725	CcSEcCtD
Tretinoin—Hyperaesthesia—Temozolomide—malignant glioma	0.000428	0.00725	CcSEcCtD
Tretinoin—ALDH1A2—brain—malignant glioma	0.000413	0.0132	CbGeAlD
Tretinoin—CRABP1—brain—malignant glioma	0.000399	0.0128	CbGeAlD
Tretinoin—RARB—cerebellum—malignant glioma	0.000397	0.0127	CbGeAlD
Tretinoin—RXRG—central nervous system—malignant glioma	0.000397	0.0127	CbGeAlD
Tretinoin—ALDH1A1—central nervous system—malignant glioma	0.000378	0.0121	CbGeAlD
Tretinoin—Drug interaction—Carmustine—malignant glioma	0.000374	0.00635	CcSEcCtD
Tretinoin—RXRB—central nervous system—malignant glioma	0.000373	0.012	CbGeAlD
Tretinoin—ALDH1A1—cerebellum—malignant glioma	0.00037	0.0118	CbGeAlD
Tretinoin—Leukocytosis—Carmustine—malignant glioma	0.00037	0.00626	CcSEcCtD
Tretinoin—RXRB—cerebellum—malignant glioma	0.000365	0.0117	CbGeAlD
Tretinoin—Herpes simplex—Temozolomide—malignant glioma	0.000364	0.00617	CcSEcCtD
Tretinoin—CRABP2—brain—malignant glioma	0.000361	0.0115	CbGeAlD
Tretinoin—RXRA—brain—malignant glioma	0.000359	0.0115	CbGeAlD
Tretinoin—Gait disturbance—Carmustine—malignant glioma	0.000356	0.00603	CcSEcCtD
Tretinoin—Hearing impaired—Temozolomide—malignant glioma	0.000353	0.00598	CcSEcCtD
Tretinoin—Neck pain—Carmustine—malignant glioma	0.000352	0.00596	CcSEcCtD
Tretinoin—Injection site reaction—Carmustine—malignant glioma	0.000345	0.00585	CcSEcCtD
Tretinoin—Gait disturbance—Temozolomide—malignant glioma	0.000344	0.00583	CcSEcCtD
Tretinoin—Respiratory failure—Temozolomide—malignant glioma	0.000342	0.00579	CcSEcCtD
Tretinoin—Musculoskeletal pain—Temozolomide—malignant glioma	0.00034	0.00576	CcSEcCtD
Tretinoin—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.000336	0.00569	CcSEcCtD
Tretinoin—Depressed level of consciousness—Carmustine—malignant glioma	0.000335	0.00569	CcSEcCtD
Tretinoin—Skin exfoliation—Carmustine—malignant glioma	0.000332	0.00562	CcSEcCtD
Tretinoin—Candida infection—Carmustine—malignant glioma	0.000332	0.00562	CcSEcCtD
Tretinoin—RARG—central nervous system—malignant glioma	0.000331	0.0106	CbGeAlD
Tretinoin—Depressed level of consciousness—Temozolomide—malignant glioma	0.000324	0.00549	CcSEcCtD
Tretinoin—RARG—cerebellum—malignant glioma	0.000324	0.0104	CbGeAlD
Tretinoin—RARB—brain—malignant glioma	0.000322	0.0103	CbGeAlD
Tretinoin—Skin exfoliation—Temozolomide—malignant glioma	0.00032	0.00543	CcSEcCtD
Tretinoin—Candida infection—Temozolomide—malignant glioma	0.00032	0.00543	CcSEcCtD
Tretinoin—Coma—Carmustine—malignant glioma	0.000317	0.00538	CcSEcCtD
Tretinoin—RXRG—brain—malignant glioma	0.000315	0.0101	CbGeAlD
Tretinoin—RARA—central nervous system—malignant glioma	0.000312	0.00998	CbGeAlD
Tretinoin—Dry eye—Temozolomide—malignant glioma	0.00031	0.00526	CcSEcCtD
Tretinoin—RARA—cerebellum—malignant glioma	0.000304	0.00975	CbGeAlD
Tretinoin—Sepsis—Carmustine—malignant glioma	0.000301	0.00511	CcSEcCtD
Tretinoin—ALDH1A1—brain—malignant glioma	0.0003	0.00962	CbGeAlD
Tretinoin—RXRB—brain—malignant glioma	0.000296	0.00949	CbGeAlD
Tretinoin—Phlebitis—Carmustine—malignant glioma	0.000293	0.00496	CcSEcCtD
Tretinoin—Diabetes mellitus—Carmustine—malignant glioma	0.00029	0.00491	CcSEcCtD
Tretinoin—Swelling—Carmustine—malignant glioma	0.000286	0.00484	CcSEcCtD
Tretinoin—Ear pain—Temozolomide—malignant glioma	0.000286	0.00484	CcSEcCtD
Tretinoin—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00028	0.00475	CcSEcCtD
Tretinoin—Deafness—Temozolomide—malignant glioma	0.000272	0.00462	CcSEcCtD
Tretinoin—Nasal congestion—Temozolomide—malignant glioma	0.000267	0.00453	CcSEcCtD
Tretinoin—RARG—brain—malignant glioma	0.000263	0.00842	CbGeAlD
Tretinoin—Dermatitis exfoliative—Temozolomide—malignant glioma	0.000258	0.00438	CcSEcCtD
Tretinoin—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000252	0.00427	CcSEcCtD
Tretinoin—RARA—brain—malignant glioma	0.000247	0.00792	CbGeAlD
Tretinoin—Face oedema—Carmustine—malignant glioma	0.000243	0.00413	CcSEcCtD
Tretinoin—Affect lability—Temozolomide—malignant glioma	0.00024	0.00407	CcSEcCtD
Tretinoin—Face oedema—Temozolomide—malignant glioma	0.000235	0.00399	CcSEcCtD
Tretinoin—Mood swings—Temozolomide—malignant glioma	0.000231	0.00391	CcSEcCtD
Tretinoin—Dehydration—Temozolomide—malignant glioma	0.000227	0.00384	CcSEcCtD
Tretinoin—Dry skin—Temozolomide—malignant glioma	0.000223	0.00379	CcSEcCtD
Tretinoin—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000219	0.00372	CcSEcCtD
Tretinoin—Dysphagia—Carmustine—malignant glioma	0.000218	0.00369	CcSEcCtD
Tretinoin—CYP2A6—cerebellum—malignant glioma	0.000215	0.00688	CbGeAlD
Tretinoin—Abdominal distension—Temozolomide—malignant glioma	0.000212	0.00359	CcSEcCtD
Tretinoin—Dysphagia—Temozolomide—malignant glioma	0.000211	0.00357	CcSEcCtD
Tretinoin—Sweating increased—Temozolomide—malignant glioma	0.000205	0.00348	CcSEcCtD
Tretinoin—Neutropenia—Carmustine—malignant glioma	0.000204	0.00345	CcSEcCtD
Tretinoin—Dysuria—Temozolomide—malignant glioma	0.000197	0.00334	CcSEcCtD
Tretinoin—Neutropenia—Temozolomide—malignant glioma	0.000197	0.00334	CcSEcCtD
Tretinoin—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000196	0.00332	CcSEcCtD
Tretinoin—Pneumonia—Carmustine—malignant glioma	0.000195	0.00331	CcSEcCtD
Tretinoin—Pollakiuria—Temozolomide—malignant glioma	0.000195	0.0033	CcSEcCtD
Tretinoin—Depression—Carmustine—malignant glioma	0.000194	0.00328	CcSEcCtD
Tretinoin—Photosensitivity reaction—Temozolomide—malignant glioma	0.000192	0.00326	CcSEcCtD
Tretinoin—Weight increased—Temozolomide—malignant glioma	0.000192	0.00325	CcSEcCtD
Tretinoin—Renal failure—Carmustine—malignant glioma	0.000191	0.00324	CcSEcCtD
Tretinoin—Weight decreased—Temozolomide—malignant glioma	0.00019	0.00323	CcSEcCtD
Tretinoin—Neuropathy peripheral—Carmustine—malignant glioma	0.00019	0.00323	CcSEcCtD
Tretinoin—Stomatitis—Carmustine—malignant glioma	0.000189	0.00321	CcSEcCtD
Tretinoin—Urinary tract infection—Carmustine—malignant glioma	0.000189	0.0032	CcSEcCtD
Tretinoin—Pneumonia—Temozolomide—malignant glioma	0.000189	0.0032	CcSEcCtD
Tretinoin—Infestation—Temozolomide—malignant glioma	0.000188	0.00318	CcSEcCtD
Tretinoin—Infestation NOS—Temozolomide—malignant glioma	0.000188	0.00318	CcSEcCtD
Tretinoin—Depression—Temozolomide—malignant glioma	0.000187	0.00317	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000186	0.00316	CcSEcCtD
Tretinoin—Neuropathy peripheral—Temozolomide—malignant glioma	0.000184	0.00312	CcSEcCtD
Tretinoin—Stomatitis—Temozolomide—malignant glioma	0.000183	0.0031	CcSEcCtD
Tretinoin—Urinary tract infection—Temozolomide—malignant glioma	0.000182	0.00309	CcSEcCtD
Tretinoin—Sinusitis—Temozolomide—malignant glioma	0.000176	0.00299	CcSEcCtD
Tretinoin—Haemoglobin—Carmustine—malignant glioma	0.000175	0.00297	CcSEcCtD
Tretinoin—CYP2A6—brain—malignant glioma	0.000175	0.00559	CbGeAlD
Tretinoin—Haemorrhage—Carmustine—malignant glioma	0.000174	0.00296	CcSEcCtD
Tretinoin—Hypoaesthesia—Carmustine—malignant glioma	0.000174	0.00294	CcSEcCtD
Tretinoin—Hallucination—Carmustine—malignant glioma	0.000174	0.00294	CcSEcCtD
Tretinoin—Oedema peripheral—Carmustine—malignant glioma	0.000172	0.00291	CcSEcCtD
Tretinoin—Haemoglobin—Temozolomide—malignant glioma	0.000169	0.00287	CcSEcCtD
Tretinoin—Haemorrhage—Temozolomide—malignant glioma	0.000169	0.00286	CcSEcCtD
Tretinoin—Hepatitis—Temozolomide—malignant glioma	0.000169	0.00286	CcSEcCtD
Tretinoin—Visual impairment—Carmustine—malignant glioma	0.000168	0.00285	CcSEcCtD
Tretinoin—Hypoaesthesia—Temozolomide—malignant glioma	0.000168	0.00284	CcSEcCtD
Tretinoin—Hallucination—Temozolomide—malignant glioma	0.000168	0.00284	CcSEcCtD
Tretinoin—Pharyngitis—Temozolomide—malignant glioma	0.000167	0.00284	CcSEcCtD
Tretinoin—Urinary tract disorder—Temozolomide—malignant glioma	0.000166	0.00282	CcSEcCtD
Tretinoin—Oedema peripheral—Temozolomide—malignant glioma	0.000166	0.00281	CcSEcCtD
Tretinoin—Urethral disorder—Temozolomide—malignant glioma	0.000165	0.0028	CcSEcCtD
Tretinoin—Eye disorder—Carmustine—malignant glioma	0.000163	0.00276	CcSEcCtD
Tretinoin—Visual impairment—Temozolomide—malignant glioma	0.000162	0.00275	CcSEcCtD
Tretinoin—Flushing—Carmustine—malignant glioma	0.000162	0.00274	CcSEcCtD
Tretinoin—Erythema multiforme—Temozolomide—malignant glioma	0.000159	0.0027	CcSEcCtD
Tretinoin—Eye disorder—Temozolomide—malignant glioma	0.000158	0.00267	CcSEcCtD
Tretinoin—Tinnitus—Temozolomide—malignant glioma	0.000157	0.00266	CcSEcCtD
Tretinoin—Flushing—Temozolomide—malignant glioma	0.000156	0.00265	CcSEcCtD
Tretinoin—Arrhythmia—Carmustine—malignant glioma	0.000156	0.00264	CcSEcCtD
Tretinoin—Alopecia—Carmustine—malignant glioma	0.000154	0.00261	CcSEcCtD
Tretinoin—Angiopathy—Temozolomide—malignant glioma	0.000153	0.00259	CcSEcCtD
Tretinoin—Mental disorder—Carmustine—malignant glioma	0.000153	0.00259	CcSEcCtD
Tretinoin—Malnutrition—Carmustine—malignant glioma	0.000152	0.00257	CcSEcCtD
Tretinoin—Erythema—Carmustine—malignant glioma	0.000152	0.00257	CcSEcCtD
Tretinoin—Chills—Temozolomide—malignant glioma	0.000151	0.00256	CcSEcCtD
Tretinoin—Alopecia—Temozolomide—malignant glioma	0.000149	0.00252	CcSEcCtD
Tretinoin—Mental disorder—Temozolomide—malignant glioma	0.000148	0.0025	CcSEcCtD
Tretinoin—Back pain—Carmustine—malignant glioma	0.000147	0.00249	CcSEcCtD
Tretinoin—Erythema—Temozolomide—malignant glioma	0.000147	0.00249	CcSEcCtD
Tretinoin—Malnutrition—Temozolomide—malignant glioma	0.000147	0.00249	CcSEcCtD
Tretinoin—Vision blurred—Carmustine—malignant glioma	0.000143	0.00243	CcSEcCtD
Tretinoin—Tremor—Carmustine—malignant glioma	0.000142	0.00241	CcSEcCtD
Tretinoin—Back pain—Temozolomide—malignant glioma	0.000142	0.00241	CcSEcCtD
Tretinoin—Anaemia—Carmustine—malignant glioma	0.00014	0.00238	CcSEcCtD
Tretinoin—Agitation—Carmustine—malignant glioma	0.00014	0.00237	CcSEcCtD
Tretinoin—Vision blurred—Temozolomide—malignant glioma	0.000138	0.00234	CcSEcCtD
Tretinoin—Tremor—Temozolomide—malignant glioma	0.000137	0.00233	CcSEcCtD
Tretinoin—Ill-defined disorder—Temozolomide—malignant glioma	0.000136	0.00231	CcSEcCtD
Tretinoin—Anaemia—Temozolomide—malignant glioma	0.000136	0.0023	CcSEcCtD
Tretinoin—Agitation—Temozolomide—malignant glioma	0.000135	0.00229	CcSEcCtD
Tretinoin—Malaise—Temozolomide—malignant glioma	0.000132	0.00224	CcSEcCtD
Tretinoin—Convulsion—Carmustine—malignant glioma	0.000132	0.00223	CcSEcCtD
Tretinoin—Hypertension—Carmustine—malignant glioma	0.000131	0.00222	CcSEcCtD
Tretinoin—Palpitations—Temozolomide—malignant glioma	0.00013	0.0022	CcSEcCtD
Tretinoin—Myalgia—Carmustine—malignant glioma	0.000129	0.00219	CcSEcCtD
Tretinoin—Chest pain—Carmustine—malignant glioma	0.000129	0.00219	CcSEcCtD
Tretinoin—Anxiety—Carmustine—malignant glioma	0.000129	0.00218	CcSEcCtD
Tretinoin—Cough—Temozolomide—malignant glioma	0.000128	0.00217	CcSEcCtD
Tretinoin—Convulsion—Temozolomide—malignant glioma	0.000127	0.00216	CcSEcCtD
Tretinoin—Hypertension—Temozolomide—malignant glioma	0.000127	0.00215	CcSEcCtD
Tretinoin—Confusional state—Carmustine—malignant glioma	0.000125	0.00212	CcSEcCtD
Tretinoin—Myalgia—Temozolomide—malignant glioma	0.000125	0.00212	CcSEcCtD
Tretinoin—Arthralgia—Temozolomide—malignant glioma	0.000125	0.00212	CcSEcCtD
Tretinoin—Anxiety—Temozolomide—malignant glioma	0.000124	0.00211	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000124	0.0021	CcSEcCtD
Tretinoin—Oedema—Carmustine—malignant glioma	0.000124	0.0021	CcSEcCtD
Tretinoin—Discomfort—Temozolomide—malignant glioma	0.000123	0.00209	CcSEcCtD
Tretinoin—Infection—Carmustine—malignant glioma	0.000123	0.00209	CcSEcCtD
Tretinoin—Dry mouth—Temozolomide—malignant glioma	0.000122	0.00207	CcSEcCtD
Tretinoin—Thrombocytopenia—Carmustine—malignant glioma	0.000121	0.00206	CcSEcCtD
Tretinoin—Tachycardia—Carmustine—malignant glioma	0.000121	0.00205	CcSEcCtD
Tretinoin—Confusional state—Temozolomide—malignant glioma	0.000121	0.00205	CcSEcCtD
Tretinoin—Oedema—Temozolomide—malignant glioma	0.00012	0.00203	CcSEcCtD
Tretinoin—Anaphylactic shock—Temozolomide—malignant glioma	0.00012	0.00203	CcSEcCtD
Tretinoin—Infection—Temozolomide—malignant glioma	0.000119	0.00202	CcSEcCtD
Tretinoin—Anorexia—Carmustine—malignant glioma	0.000118	0.002	CcSEcCtD
Tretinoin—Nervous system disorder—Temozolomide—malignant glioma	0.000117	0.00199	CcSEcCtD
Tretinoin—Thrombocytopenia—Temozolomide—malignant glioma	0.000117	0.00199	CcSEcCtD
Tretinoin—Skin disorder—Temozolomide—malignant glioma	0.000116	0.00197	CcSEcCtD
Tretinoin—Hypotension—Carmustine—malignant glioma	0.000116	0.00196	CcSEcCtD
Tretinoin—Hyperhidrosis—Temozolomide—malignant glioma	0.000116	0.00196	CcSEcCtD
Tretinoin—Anorexia—Temozolomide—malignant glioma	0.000114	0.00193	CcSEcCtD
Tretinoin—CYP1A1—central nervous system—malignant glioma	0.000114	0.00365	CbGeAlD
Tretinoin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000113	0.00191	CcSEcCtD
Tretinoin—Insomnia—Carmustine—malignant glioma	0.000112	0.0019	CcSEcCtD
Tretinoin—Paraesthesia—Carmustine—malignant glioma	0.000111	0.00189	CcSEcCtD
Tretinoin—CYP2B6—central nervous system—malignant glioma	0.000111	0.00355	CbGeAlD
Tretinoin—Dyspnoea—Carmustine—malignant glioma	0.00011	0.00187	CcSEcCtD
Tretinoin—Somnolence—Carmustine—malignant glioma	0.00011	0.00187	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000109	0.00185	CcSEcCtD
Tretinoin—Insomnia—Temozolomide—malignant glioma	0.000108	0.00184	CcSEcCtD
Tretinoin—Decreased appetite—Carmustine—malignant glioma	0.000108	0.00183	CcSEcCtD
Tretinoin—Paraesthesia—Temozolomide—malignant glioma	0.000108	0.00182	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Carmustine—malignant glioma	0.000107	0.00181	CcSEcCtD
Tretinoin—Dyspnoea—Temozolomide—malignant glioma	0.000107	0.00181	CcSEcCtD
Tretinoin—Somnolence—Temozolomide—malignant glioma	0.000106	0.0018	CcSEcCtD
Tretinoin—Pain—Carmustine—malignant glioma	0.000106	0.0018	CcSEcCtD
Tretinoin—Constipation—Carmustine—malignant glioma	0.000106	0.0018	CcSEcCtD
Tretinoin—Dyspepsia—Temozolomide—malignant glioma	0.000105	0.00179	CcSEcCtD
Tretinoin—Decreased appetite—Temozolomide—malignant glioma	0.000104	0.00176	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000103	0.00175	CcSEcCtD
Tretinoin—Fatigue—Temozolomide—malignant glioma	0.000103	0.00175	CcSEcCtD
Tretinoin—Constipation—Temozolomide—malignant glioma	0.000102	0.00174	CcSEcCtD
Tretinoin—Pain—Temozolomide—malignant glioma	0.000102	0.00174	CcSEcCtD
Tretinoin—Feeling abnormal—Carmustine—malignant glioma	0.000102	0.00173	CcSEcCtD
Tretinoin—Gastrointestinal pain—Carmustine—malignant glioma	0.000101	0.00172	CcSEcCtD
Tretinoin—Feeling abnormal—Temozolomide—malignant glioma	9.87e-05	0.00167	CcSEcCtD
Tretinoin—CYP2C8—brain—malignant glioma	9.8e-05	0.00314	CbGeAlD
Tretinoin—Body temperature increased—Carmustine—malignant glioma	9.8e-05	0.00166	CcSEcCtD
Tretinoin—Abdominal pain—Carmustine—malignant glioma	9.8e-05	0.00166	CcSEcCtD
Tretinoin—Gastrointestinal pain—Temozolomide—malignant glioma	9.79e-05	0.00166	CcSEcCtD
Tretinoin—Urticaria—Temozolomide—malignant glioma	9.51e-05	0.00161	CcSEcCtD
Tretinoin—Body temperature increased—Temozolomide—malignant glioma	9.47e-05	0.0016	CcSEcCtD
Tretinoin—Abdominal pain—Temozolomide—malignant glioma	9.47e-05	0.0016	CcSEcCtD
Tretinoin—Hypersensitivity—Carmustine—malignant glioma	9.13e-05	0.00155	CcSEcCtD
Tretinoin—CYP1A1—brain—malignant glioma	9.04e-05	0.0029	CbGeAlD
Tretinoin—Asthenia—Carmustine—malignant glioma	8.89e-05	0.00151	CcSEcCtD
Tretinoin—Hypersensitivity—Temozolomide—malignant glioma	8.82e-05	0.0015	CcSEcCtD
Tretinoin—CYP2B6—brain—malignant glioma	8.79e-05	0.00281	CbGeAlD
Tretinoin—Asthenia—Temozolomide—malignant glioma	8.59e-05	0.00146	CcSEcCtD
Tretinoin—Diarrhoea—Carmustine—malignant glioma	8.48e-05	0.00144	CcSEcCtD
Tretinoin—Pruritus—Temozolomide—malignant glioma	8.47e-05	0.00144	CcSEcCtD
Tretinoin—CYP3A4—central nervous system—malignant glioma	8.36e-05	0.00268	CbGeAlD
Tretinoin—Dizziness—Carmustine—malignant glioma	8.19e-05	0.00139	CcSEcCtD
Tretinoin—Diarrhoea—Temozolomide—malignant glioma	8.19e-05	0.00139	CcSEcCtD
Tretinoin—Dizziness—Temozolomide—malignant glioma	7.92e-05	0.00134	CcSEcCtD
Tretinoin—Vomiting—Carmustine—malignant glioma	7.88e-05	0.00134	CcSEcCtD
Tretinoin—Rash—Carmustine—malignant glioma	7.81e-05	0.00132	CcSEcCtD
Tretinoin—Dermatitis—Carmustine—malignant glioma	7.81e-05	0.00132	CcSEcCtD
Tretinoin—Headache—Carmustine—malignant glioma	7.76e-05	0.00132	CcSEcCtD
Tretinoin—Vomiting—Temozolomide—malignant glioma	7.61e-05	0.00129	CcSEcCtD
Tretinoin—Rash—Temozolomide—malignant glioma	7.55e-05	0.00128	CcSEcCtD
Tretinoin—Dermatitis—Temozolomide—malignant glioma	7.54e-05	0.00128	CcSEcCtD
Tretinoin—Headache—Temozolomide—malignant glioma	7.5e-05	0.00127	CcSEcCtD
Tretinoin—Nausea—Carmustine—malignant glioma	7.36e-05	0.00125	CcSEcCtD
Tretinoin—Nausea—Temozolomide—malignant glioma	7.11e-05	0.00121	CcSEcCtD
Tretinoin—CYP3A5—Metabolism—CYP2B6—malignant glioma	5.8e-06	8.89e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ASMT—malignant glioma	5.74e-06	8.79e-05	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—MYC—malignant glioma	5.73e-06	8.79e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CAT—malignant glioma	5.71e-06	8.75e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GSTT1—malignant glioma	5.63e-06	8.62e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.61e-06	8.59e-05	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PIK3CA—malignant glioma	5.6e-06	8.59e-05	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PIK3CA—malignant glioma	5.6e-06	8.59e-05	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PIK3CA—malignant glioma	5.6e-06	8.59e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	5.49e-06	8.42e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP2B6—malignant glioma	5.48e-06	8.4e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—VEGFA—malignant glioma	5.46e-06	8.37e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—IDH1—malignant glioma	5.43e-06	8.32e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—STAT3—malignant glioma	5.41e-06	8.29e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.4e-06	8.28e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—BCAN—malignant glioma	5.39e-06	8.27e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—NCOR1—malignant glioma	5.39e-06	8.26e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—IDH2—malignant glioma	5.34e-06	8.19e-05	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—MYC—malignant glioma	5.34e-06	8.18e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—GSTP1—malignant glioma	5.32e-06	8.16e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—IDH1—malignant glioma	5.3e-06	8.13e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTGS1—malignant glioma	5.27e-06	8.08e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—SPHK1—malignant glioma	5.25e-06	8.05e-05	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—MYC—malignant glioma	5.24e-06	8.04e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CAT—malignant glioma	5.18e-06	7.94e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GSTT1—malignant glioma	5.16e-06	7.9e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP2C18—malignant glioma	5.14e-06	7.88e-05	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—MYC—malignant glioma	5.14e-06	7.88e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—SPHK1—malignant glioma	5.13e-06	7.87e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	5.04e-06	7.72e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP2C18—malignant glioma	5.03e-06	7.71e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—CAV1—malignant glioma	5.03e-06	7.7e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP2B6—malignant glioma	5.02e-06	7.7e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—IDH1—malignant glioma	5.01e-06	7.68e-05	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—AKT1—malignant glioma	4.93e-06	7.56e-05	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—MYC—malignant glioma	4.93e-06	7.56e-05	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—MYC—malignant glioma	4.93e-06	7.56e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—EGFR—malignant glioma	4.91e-06	7.53e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—BCHE—malignant glioma	4.9e-06	7.51e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—NCOR1—malignant glioma	4.89e-06	7.5e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—SPHK1—malignant glioma	4.85e-06	7.43e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—SLC5A5—malignant glioma	4.84e-06	7.42e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTGS1—malignant glioma	4.83e-06	7.41e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.8e-06	7.36e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—NOTCH1—malignant glioma	4.78e-06	7.32e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP2C18—malignant glioma	4.75e-06	7.28e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—TNF—malignant glioma	4.68e-06	7.17e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—KRAS—malignant glioma	4.64e-06	7.12e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—IDH1—malignant glioma	4.59e-06	7.04e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PIK3CG—malignant glioma	4.58e-06	7.02e-05	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—AKT1—malignant glioma	4.58e-06	7.02e-05	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—AKT1—malignant glioma	4.58e-06	7.02e-05	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—AKT1—malignant glioma	4.58e-06	7.02e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—PPARG—malignant glioma	4.51e-06	6.91e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—BCHE—malignant glioma	4.49e-06	6.89e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.48e-06	6.87e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—COX8A—malignant glioma	4.45e-06	6.82e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SPHK1—malignant glioma	4.45e-06	6.81e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—SLC5A5—malignant glioma	4.44e-06	6.8e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PPARG—malignant glioma	4.42e-06	6.77e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CAV1—malignant glioma	4.39e-06	6.73e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP2C18—malignant glioma	4.35e-06	6.68e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—IDH2—malignant glioma	4.35e-06	6.66e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GSTT1—malignant glioma	4.16e-06	6.38e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.11e-06	6.29e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.1e-06	6.28e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP2B6—malignant glioma	4.09e-06	6.27e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.08e-06	6.25e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GSTT1—malignant glioma	4.07e-06	6.23e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PIK3CD—malignant glioma	4.03e-06	6.17e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3CG—malignant glioma	4e-06	6.13e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CAV1—malignant glioma	3.99e-06	6.11e-05	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—AKT1—malignant glioma	3.98e-06	6.1e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.94e-06	6.04e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GSTP1—malignant glioma	3.9e-06	5.98e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTGS1—malignant glioma	3.9e-06	5.98e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PPARG—malignant glioma	3.86e-06	5.92e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GSTT1—malignant glioma	3.84e-06	5.89e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTGS1—malignant glioma	3.81e-06	5.84e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.81e-06	5.84e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CAT—malignant glioma	3.79e-06	5.82e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ASMT—malignant glioma	3.78e-06	5.8e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.74e-06	5.73e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—IDH1—malignant glioma	3.74e-06	5.73e-05	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—AKT1—malignant glioma	3.64e-06	5.57e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CG—malignant glioma	3.63e-06	5.57e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—BCHE—malignant glioma	3.62e-06	5.56e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SPHK1—malignant glioma	3.62e-06	5.55e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.61e-06	5.53e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTGS1—malignant glioma	3.6e-06	5.52e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.59e-06	5.5e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—NCOR1—malignant glioma	3.58e-06	5.49e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—SLC5A5—malignant glioma	3.58e-06	5.49e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GSTP1—malignant glioma	3.57e-06	5.48e-05	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—AKT1—malignant glioma	3.57e-06	5.47e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—BCAN—malignant glioma	3.56e-06	5.45e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP2C18—malignant glioma	3.54e-06	5.43e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—BCHE—malignant glioma	3.54e-06	5.43e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTT1—malignant glioma	3.52e-06	5.4e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3CD—malignant glioma	3.52e-06	5.39e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PIK3CB—malignant glioma	3.51e-06	5.38e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PPARG—malignant glioma	3.5e-06	5.37e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—SLC5A5—malignant glioma	3.5e-06	5.36e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—AKT1—malignant glioma	3.48e-06	5.34e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CAT—malignant glioma	3.48e-06	5.33e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PTGS2—malignant glioma	3.48e-06	5.33e-05	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—AKT1—malignant glioma	3.42e-06	5.24e-05	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—AKT1—malignant glioma	3.42e-06	5.24e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—BCHE—malignant glioma	3.35e-06	5.13e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.34e-06	5.12e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—SLC5A5—malignant glioma	3.31e-06	5.07e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTGS1—malignant glioma	3.3e-06	5.06e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.29e-06	5.04e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—NCOR1—malignant glioma	3.28e-06	5.03e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CD—malignant glioma	3.19e-06	4.89e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.13e-06	4.79e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.1e-06	4.75e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—BCHE—malignant glioma	3.07e-06	4.7e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3CB—malignant glioma	3.07e-06	4.7e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.04e-06	4.67e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTGS2—malignant glioma	3.04e-06	4.66e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PTEN—malignant glioma	3.03e-06	4.65e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SLC5A5—malignant glioma	3.03e-06	4.65e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.94e-06	4.5e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CAV1—malignant glioma	2.92e-06	4.48e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GSTP1—malignant glioma	2.88e-06	4.42e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—IDH2—malignant glioma	2.87e-06	4.4e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTT1—malignant glioma	2.87e-06	4.39e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.87e-06	4.39e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.84e-06	4.35e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GSTP1—malignant glioma	2.82e-06	4.32e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CAT—malignant glioma	2.81e-06	4.3e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CB—malignant glioma	2.78e-06	4.27e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTGS2—malignant glioma	2.76e-06	4.23e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CAT—malignant glioma	2.74e-06	4.2e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.7e-06	4.14e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.7e-06	4.13e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTGS1—malignant glioma	2.69e-06	4.12e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CAV1—malignant glioma	2.68e-06	4.1e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.68e-06	4.1e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GSTP1—malignant glioma	2.66e-06	4.08e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CG—malignant glioma	2.66e-06	4.08e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—NCOR1—malignant glioma	2.65e-06	4.06e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTEN—malignant glioma	2.65e-06	4.06e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CAT—malignant glioma	2.59e-06	3.97e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—NCOR1—malignant glioma	2.59e-06	3.97e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—MYC—malignant glioma	2.57e-06	3.94e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PPARG—malignant glioma	2.57e-06	3.94e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—BCHE—malignant glioma	2.5e-06	3.83e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.48e-06	3.8e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SLC5A5—malignant glioma	2.47e-06	3.78e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—IDH1—malignant glioma	2.47e-06	3.78e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—NCOR1—malignant glioma	2.45e-06	3.75e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTP1—malignant glioma	2.44e-06	3.74e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CG—malignant glioma	2.44e-06	3.74e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTEN—malignant glioma	2.4e-06	3.69e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SPHK1—malignant glioma	2.39e-06	3.66e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CAT—malignant glioma	2.38e-06	3.64e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PPARG—malignant glioma	2.35e-06	3.61e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CD—malignant glioma	2.34e-06	3.59e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.34e-06	3.58e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.33e-06	3.58e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.31e-06	3.54e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—NCOR1—malignant glioma	2.24e-06	3.44e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CAV1—malignant glioma	2.16e-06	3.31e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CD—malignant glioma	2.14e-06	3.29e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PIK3CA—malignant glioma	2.14e-06	3.28e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CAV1—malignant glioma	2.11e-06	3.24e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CB—malignant glioma	2.04e-06	3.12e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTGS2—malignant glioma	2.02e-06	3.1e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.02e-06	3.09e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CAV1—malignant glioma	1.99e-06	3.06e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTP1—malignant glioma	1.99e-06	3.05e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CG—malignant glioma	1.97e-06	3.02e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CAT—malignant glioma	1.93e-06	2.96e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CG—malignant glioma	1.92e-06	2.95e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.91e-06	2.92e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PPARG—malignant glioma	1.9e-06	2.91e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTT1—malignant glioma	1.89e-06	2.9e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3CA—malignant glioma	1.87e-06	2.87e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CB—malignant glioma	1.87e-06	2.86e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PPARG—malignant glioma	1.86e-06	2.85e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTGS2—malignant glioma	1.85e-06	2.84e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CAV1—malignant glioma	1.83e-06	2.8e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NCOR1—malignant glioma	1.83e-06	2.8e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CG—malignant glioma	1.82e-06	2.79e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—AKT1—malignant glioma	1.78e-06	2.73e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTGS1—malignant glioma	1.77e-06	2.72e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTEN—malignant glioma	1.76e-06	2.7e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PPARG—malignant glioma	1.75e-06	2.69e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.75e-06	2.68e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—AKT1—malignant glioma	1.75e-06	2.68e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CD—malignant glioma	1.73e-06	2.65e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CA—malignant glioma	1.7e-06	2.6e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CD—malignant glioma	1.69e-06	2.59e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CG—malignant glioma	1.67e-06	2.55e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—BCHE—malignant glioma	1.65e-06	2.52e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.63e-06	2.49e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTEN—malignant glioma	1.61e-06	2.48e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PPARG—malignant glioma	1.61e-06	2.46e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CD—malignant glioma	1.6e-06	2.45e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—AKT1—malignant glioma	1.53e-06	2.34e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CB—malignant glioma	1.51e-06	2.31e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTGS2—malignant glioma	1.49e-06	2.29e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CAV1—malignant glioma	1.49e-06	2.28e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CB—malignant glioma	1.47e-06	2.26e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CD—malignant glioma	1.46e-06	2.24e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTGS2—malignant glioma	1.46e-06	2.24e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.42e-06	2.18e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CB—malignant glioma	1.39e-06	2.13e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—AKT1—malignant glioma	1.39e-06	2.12e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTGS2—malignant glioma	1.38e-06	2.11e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.36e-06	2.08e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTP1—malignant glioma	1.31e-06	2.01e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PPARG—malignant glioma	1.31e-06	2.01e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTEN—malignant glioma	1.3e-06	2e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CB—malignant glioma	1.28e-06	1.96e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CAT—malignant glioma	1.28e-06	1.95e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTEN—malignant glioma	1.27e-06	1.95e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTGS2—malignant glioma	1.26e-06	1.94e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CA—malignant glioma	1.24e-06	1.9e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NCOR1—malignant glioma	1.2e-06	1.85e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTEN—malignant glioma	1.2e-06	1.84e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.19e-06	1.83e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CA—malignant glioma	1.14e-06	1.75e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTEN—malignant glioma	1.1e-06	1.69e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.04e-06	1.59e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTGS2—malignant glioma	1.03e-06	1.58e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—AKT1—malignant glioma	1.02e-06	1.56e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CAV1—malignant glioma	9.82e-07	1.5e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—AKT1—malignant glioma	9.31e-07	1.43e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CA—malignant glioma	9.19e-07	1.41e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CA—malignant glioma	8.98e-07	1.38e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTEN—malignant glioma	8.98e-07	1.38e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CG—malignant glioma	8.94e-07	1.37e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PPARG—malignant glioma	8.63e-07	1.32e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CA—malignant glioma	8.49e-07	1.3e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CD—malignant glioma	7.86e-07	1.2e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CA—malignant glioma	7.78e-07	1.19e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—AKT1—malignant glioma	7.51e-07	1.15e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—AKT1—malignant glioma	7.34e-07	1.12e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—AKT1—malignant glioma	6.93e-07	1.06e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CB—malignant glioma	6.85e-07	1.05e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTGS2—malignant glioma	6.79e-07	1.04e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—AKT1—malignant glioma	6.36e-07	9.74e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CA—malignant glioma	6.33e-07	9.71e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTEN—malignant glioma	5.92e-07	9.07e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—AKT1—malignant glioma	5.17e-07	7.93e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CA—malignant glioma	4.18e-07	6.4e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AKT1—malignant glioma	3.41e-07	5.23e-06	CbGpPWpGaD
